ArticleFrontiers in surgery2022

Surgery offers survival advantage over radiotherapy in patients who are 80 years and older with Stage I and II NSCLC: A retrospective cohort study of 7,045 patients.

Qiang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.